Cargando…
Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study
Preterm births are the leading cause of neonatal death in the United States. Previously, a spontaneous preterm birth (sPTB) predictor based on the ratio of two proteins, IBP4/SHBG, was validated as a predictor of sPTB in the Proteomic Assessment of Preterm Risk (PAPR) study. In particular, a proteom...
Autores principales: | Burchard, Julja, Polpitiya, Ashoka D., Fox, Angela C., Randolph, Todd L., Fleischer, Tracey C., Dufford, Max T., Garite, Thomas J., Critchfield, Gregory C., Boniface, J. Jay, Saade, George R., Kearney, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584743/ https://www.ncbi.nlm.nih.gov/pubmed/34768605 http://dx.doi.org/10.3390/jcm10215088 |
Ejemplares similares
-
Better Estimation of Spontaneous Preterm Birth Prediction Performance through Improved Gestational Age Dating
por: Burchard, Julja, et al.
Publicado: (2022) -
Effects of Selective Exclusion of Patients on Preterm Birth Test Performance
por: Boniface, J. Jay, et al.
Publicado: (2019) -
Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction
por: Grabner, Michael, et al.
Publicado: (2021) -
Corrigendum to “Analytical validation of protein biomarkers for risk of spontaneous preterm birth” [Clin. Mass Spectrom. 3 (2017) 25–38]
por: Bradford, Chad, et al.
Publicado: (2022) -
Prediction and Prevention of Preterm Birth: A Prospective, Randomized Intervention Trial
por: Branch, D. Ware, et al.
Publicado: (2021)